medigraphic.com
ISSN 1561-2937 (Print)

2021, Number 4

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (4)

Characterization of patients treated with valve replacement surgery

Cáceres RC, Valdés MA, Rodríguez NLM, Armas RNB, Naranjo-Domínguez A, González EAB

Language: Spanish
References: 45
Page: 1-9
PDF size: 414.44 Kb.


ABSTRACT

Introduction: Heart valve disease is a very common pathology.
Objective: To characterize the results of valve surgery at the Institute of Cardiology and Cardiovascular Surgery during the period 2016-2019.
Method: An observational, descriptive and retrospective study was carried out. The universe consisted of 753 patients. Results: The average age was 59.2 ± 11.0 years with a predominance of males (52.3%). Arterial hypertension was the most frequent personal pathological antecedent, predominating ex-smokers and aortic (43.9%) and mitral (28.0%) stenosing valve lesion. There was a predominance of patients with ASA III (84.6) physical status assessment, slightly decreased renal function, and left ventricular ejection fraction less than 50%.
Conclusions: The patients in this investigation had several risk factors and personal pathological antecedents, typical of patients with valvular affectations that require surgical treatment. The aforementioned justify an important limitation of the physical state at the time of surgery. Despite the fact that left ventricular function and renal function were mostly within normal parameters, a percent of patients presented depression of glomerular filtration and ventricular function.


REFERENCES

  1. William A. Zoghbi M. American Society of Echocardiography Report: Recommendations for Evaluation of the Severity of Native Valvular Regurgitation with Two-dimensional and Doppler Echocardiography J Am Soc Echocardiogr 2018; 16 (4): 777-802. Disponible en: https://dx.doi.org/10.1016/S0894-7317(03)00335-3

  2. Bonow R O. ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease JACC, 2017 (48):148. Disponible en: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.106.176857

  3. Cortes K, Medina C. Caracterización clínica y morfofuncional de pacientes operados con defectos septales y valvulopatía mitral y aórtica. Revista Cubana de cardiología y Cirugía Cardiovascular. 2019; 25 (2): 4. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/817

  4. Otto CM ,Nishimura RA , Bonow RO, Carabello BA, Erwin III JP ,Gentile F et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Disponible en: https://doi.org/10.1161/CIR.0000000000000923

  5. Arazoza Hernández A, Rodríguez Rosales E, Rodríguez Salgueiro FL, Carrasco Molina MA, Valera Pérez D. Sustitución valvular aórtica mínimamente invasiva. Primeros casos realizados en Cuba. CorSalud 2014; 6(1):105-109. Disponible en: https://www.medigraphic.com/pdfs/corsalud/cor-2014/cor141n.pdf

  6. Pipkin M, Ochoa JP, Sol MA, Verón FL, Stampone G, Blanco G, et al. Cirugía de reemplazo valvular aórtico en pacientes octogenarios: resultados perioperatorios y seguimiento a mediano plazo. Rev. Arg. Cardiol. 2014; 82:13-2020. Disponible en http://dx.doi.org/10.7775/rac.es.v81.i1.1804

  7. Lindman BR, Bonow RO, Otto CM. Current management of calcific aortic stenosis, Circ Res.2018: 11(3): 223. Disponible en: https://doi.org/10.1161/CIRCRESAHA.111.300084

  8. Vieira da Costa JC, Bodanese LC, Bueno FL, Goldani MA. Propuesta de score de riesgo preoperatorio para pacientes candidatos a cirugía cardiaca valvular. Arq Bras Cardiol. 2010; 94(4):523-30. Disponible en: https://doi.org/10.1590/S0066-782X2010005000026

  9. Roques F, Nashef SA, Michel P; EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis. 2001; 10(5):572-7; discussion 577-8. Disponible en: https://www.pubmed.ncbi.nlm.nih.gov/11603595

  10. Antonini-Canterin F, Huang G, Cervesato E, Pompilio F, Pavan D, Piazza R et al. Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension. 2003; 41:1268-72. Disponible en: https://doi.org/10.1161/01.HYP.0000070029.30058.59

  11. Azpitarte J, Alonso ÁM, García F, González JM, Paré C, Tello A. Guías de práctica clínica de la Sociedad Española de Cardiología: Rev Esp Cardiol. 2000; 53 (9): 1209-1278.Disponible en: https://www.revespcardiol.org/es-pdf-X0300893200110177

  12. Careaga-Reyna G, Martínez-Carballo G, Anza-Costa-bile LM, Ávila-Funés A. Euroscore para predecir morbimortalidad en cirugía cardiaca valvular. Cir Ciruj. 2008:76(6):497-505.Disponible en: https://www.medigraphic.com/pdfs/circir/cc-2008/cc086h.pdf

  13. Eveborn GW, Shirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis: the Troms Study. Heart 2013; 99:396-400. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22942293

  14. Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, et al. Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018 18;72(12):1397-1416. Disponible en: https://doi.org/10.1016/j.jacc.2018.06.063

  15. Henry Vera GE, Ducuara Tovar CH, Duany Díaz T, Valdés Martin A, Lisbeth González González L, López Piñeiro Y. Estenosis aórtica basada en la evidencia. Rev Cuba Cardiol Cir Cardiovasc.2018;24(1):105-123.Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/735

  16. Santangelo G, Rossi A, Toriello F, Badano L.P, Messika Zeitoun D; Faggiano P. Diagnosis and Management of Aortic Valve Stenosis: The Role of Non-Invasive Imaging. J. Clin. Med. 2021, 10 (16) 3745. Disponible en: https://doi.org/10.3390/jcm10163745

  17. Fernández R. Sustitución valvular mitral. Técnicas quirúrgicas. Prótesis valvulares. Cir Cardiovasc. 2005;12(4):321-4. Disponible en: https://doi.org/10.1016/S1134-0096(05)70345-4

  18. Borgarelli M,Buchanan JW. Historical review, epidemiology and natural history of degenerative mitral valve disease. J Vet Cardiol. 2012 ;14(1):93-101.Disponible en: http://www.sciencedirect.com/science/article/abs/pii/S1760273412000239?via%3Dihub

  19. Chandrashekhar Y, Westaby S, Narula J Mitral stenosis. Lancet. 2009; 374(9697):1271-83 Disponible en: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60994-6/fulltext

  20. I. Ferreira-González, J. Pinar-Sopena, A. Ribera, J.R. Marsal, P. Cascant, T. González-Alujas, et al. Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area. Eur J Prev Cardiol.2013; 20 (6): 1022-1030. Disponible en: http://www.academic.oup.com/eurjpc/article/20/6/1022/5928045

  21. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63: e57-185.Disponible en: https://doi.org/10.1161/CIR.0000000000000029

  22. Lancellotti P, Magne J, Donal E, Davin L, O’Connor K, Rosca M, et al. Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol.2012; 59 (3): 235-243. Disponible en: http://www.sciencedirect.com/science/article/pii/S0735109711046614?via%3Dihub

  23. Fernández R. Sustitución valvular mitral. Técnicas quirúrgicas. Prótesis valvulares. Cir Cardiovasc. 2005;12(4):321-4. Disponible en: https://cyberleninka.org/article/n/297454

  24. Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin J S, O'Brien SM, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg 2009;87(4):1431-7. Disponible en: https://www.annalsthoracicsurgery.org/article/S0003-4975(09)00162-3/fulltext

  25. Andalia Pérez KE, Rodríguez Rodríguez V, Pérez López H. Cirugía en pacientes con enfermedad de la válvula mitral. Instituto de Cardiología y Cirugía Cardiovascular 1996-2006. Rev Cuba Cardiol Cir Cardiovasc 2015;21 (4): 11-21 Disponible en: https://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/608

  26. Mkalaluh S, Szczechowicz M, Dib B, Szabo G, Karck M, Weymann A. Outcomes and Predictors of Mortality After Mitral Valve Surgery in High-Risk Elderly Patients: The Heidelberg Experience. Med Sci Monit. 2017; 23:6193-6200. Disponible en: https://www.medscimonit.com/abstract/index/idArt/906003

  27. Mingo S, Monivas V Cobo M, Ruiz L, Castedo E, Serrano S. Cirugía valvular aórtica. Indicaciones y resultados. Cir. Cardiov. 2015;17(4):351-61. Disponible en: http://www.cyberleninka.org/article/n/966432

  28. Baumgartner H, Falk V, Bax JJ, Michele DB, Hamm C, Holm PJ, Iung B et al. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías. Rev Esp Cardiol. 2018;71(2): 110.e1-e47. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0300893217308096?via%3Dihub.

  29. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010; 11:223–244. Disponible en: https://www.academic.oup.com/ehjcimaging/article/11/3/223/2396923#

  30. Careaga-Reyna G, Martínez-Carballo G, Anza-Costabile LM, Ávila-Funés A. Euroscore para predecir morbimortalidad en cirugía cardiaca valvular. Cir Ciruj. 2008:76(6):497-505. Disponible en: https://www.medigraphic.com/pdfs/circir/cc-2008/cc086h.pdf

  31. Teniente Valente R, González Bravo FE, Chagolla Santillán MA, Acevedo Bañuelos I, Bernal-Ruíz EA, López-Luis LE et al. Validation of the EuroSCORE model in patients undergoing heart surgery in Regional Hospital of High Specialty of Bajio. Rev Mex Cardiol 2018; 29 (3): 134-143.Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=82811

  32. Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, et al. Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg. 2011; 91(6): 1798-806.Disponible en: https://doi.org/10.1016/j.athoracsur.2011.02.015

  33. Ramos MV, Pouso M, Pouso J. Incidencia acumulada de insuficiencia renal aguda en el posoperatorio de cirugía cardíaca. Rev. Urug. Cardiol. 2018; 33 (2): http://dx.doi.org/10.29277/cardio.33.2.3

  34. Vázquez YM, Álvarez Pelegrino A, Rojas Váldes Y, Leiva Torres JL. Frecuencia de complicaciones y tiempo de estadía hospitalaria en cirugía cardiovascular. Invest Medicoquir. 2018;10(1):56-64. Disponible en: http://www.revcimeq.sld.cu/index.php/imq/article/view/410/494

  35. Ranucci M, Johnson I, Willcox T, Baker RA, Boer C, Baumann A et al. Goal-directed perfusion to reduce acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg.2018;156;1918-27. Disponible en: https://www.jtcvs.org/article/S0022-5223(18)31029-8/fulltext

  36. De Bacco MW, Sartori AP, Sant’Anna JRM, Santos MF, Prates PR, Kalil K, et al. Fatores de risco para mortalidade hospitalar no implante de prótese valvar mecânica. Rev Bras Cir Cardiovasc. 2009; 24(3): 334-40. Disponible en : https://www.scielo.br/j/rbccv/a/YVfHNxDqV6MGhTn3D4qcZqM/?lang=pt

  37. González Kadashinskaia GO, Bello Carrasco LM, Anchundia Alvia DA. Cirugía cardíaca, complicaciones inmediatas post operatorias. Universidad y Sociedad.2020;12 (2): 293-300. Disponible en: http://scielo.sld.cu/pdf/rus/v12n2/2218-3620-rus-12-02-293.pdf.

  38. Riera M, Amézaga R, Molina M, Campillo A, Sáez de Ibarra JI, Bonnín O, et al. Mortalidad de las complicaciones postoperatorias (failure to rescue) tras cirugía cardiaca en un hospital universitario. Rev Calid Asist.2016;31(3):126---133. Disponible en: https://www.elsevier.es/es-revista-revista-calidad-asistencial-256-pdf-S1134282X16300355

  39. Fernández J, Padrón K, Paredes Á, Vázquez E, González O, González A. Predictores de bajo gasto cardíaco perioperatorio en pacientes operados de cirugía cardíaca valvular. CorSalud. 2018; 10(4):286- 93. Disponible en: https://www.revcorsalud.sld.cu/index.php/cors/article/view/389/808

  40. Dahl JS, Christensen NL, Videbæk L, Poulsen MK, Carter-Storch R, Hey TM, et al. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging 2014;7(1):142-48. Disponible en: https://doi.org/10.1161/CIRCIMAGING.113.000636

  41. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am SocEchocardiogr. 2017; 28:1–39. e14. https://doi.org/10.1093/ehjci/jev014

  42. Kang DH, Jang JY, Park SJ, Kim DH, Yun SC, Song JM, et al. Watchful observation versus early aortic valve replacement for symptomatic patients with normal flow, low-gradient severe aortic stenosis. Heart. 2015;101(17):1375-81. Disponible en: https://heart.bmj.com/content/101/17/1375

  43. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al. High- Versus Low-Gradient Severe Aortic Stenosis: Demographics, Clinical Outcomes, and Effects of the Initial Aortic Valve Replacement Strategy on Long-Term Prognosis. Circ Cardiovasc Interv. 2017;10(5): e004796. Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/CIRCINTERVENTIONS.116.004796

  44. Giuseppe Tarantini G, Buja P, Scognamiglio R, Razzolini R, Gerosa G, Isabella G, et al. Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery, European Journal of Cardio-Thoracic Surgery. 2003; 24 (6):879–885, https://doi.org/10.1016/S1010-7940(03)00575-X

  45. Egbe AC, Warnes CA. Predictor of left ventricular dysfunction after aortic valve replacement in mixed aortic valve disease. Int J Cardiol. 2017; 228:511-517. Disponible en: https://doi.org/10.1016/j.ijcard.2016.11.237




2020     |     www.medigraphic.com